10-31-2017 06:38 PM CET - Health & Medicine
Print

Dural Arteriovenous Fistulas Treatment Global Market 2017: Key Players – BD, Medtronic, B. Braun Melsungen AG, Cook, Teleflex Incorporated and More

Press release from: Market Research Future
PR Agency: Market Research Future
Dural Arteriovenous Fistulas Treatment Market
Dural Arteriovenous Fistulas Treatment Market


Executive Summary

Market Research Future published new report, titled “Dural Arteriovenous Fistulas Treatment Market -Research Report: Global Forecast till 2023”.

Dural Arteriovenous Fistulas (DAVF) Treatment Market Information: By Type (Type I, Type II, Type III), Treatment (Surgery, Stereotactic Radiosurgery, Embolization), End User (Hospitals & Clinics, Ambulatory Surgical Centers) - Global Forecast till 2023

The global dural arteriovenous fistulae treatment market is expected to grow at a CAGR of ~ 7.68 % during the forecast period 2017-2023.

GET SAMPLE REPORT @ www.marketresearchfuture.com/sample_request/4580 .

Market Synopsis of Global Dural Arteriovenous Fistulas Treatment Market:
Dural arteriovenous fistulae (DAVF) is caused by abnormal connections between arteries and veins in a protective membrane on the outer layer of the brain and spine; it is a rare disease. These abnormal blood vessels divert blood from the normal paths. If the volume of diverted blood flow is large, tissue downstream may not receive an adequate blood and oxygen supply. The symptoms vary, depending on the location of fistulae. Headaches are among the most common symptoms with all types of DAVFs. Other symptoms include visual problems, ringing in ears, heart strokes, and others.

Increasing prevalence of brain injury and neurological disorders, increasing investment in biotechnology and pharmaceutical industries in R&D, and rising need for the better treatment methods drive the growth of the market. Moreover, favorable reimbursement policies, increased applications, and significant investments in the development of advance technologies for the treatment methods likely to fuel the market growth during the forecast period 2017-2023.

As per the Centers for Disease Control and Prevention in 2014, about 2.8 million TBI-related Emergency Department (ED) visits, hospitalizations, and deaths occurred in the United States. TBI (traumatic brain injury) contributed to the deaths of nearly 50,000 people. It was diagnosed in over 282,000 hospitalized cases and over 2.5 million ED visits. These consisted of TBI alone or TBI in combination with other injuries. Adults aged over 75 years have the highest rates of TBI-related hospitalization and deaths.

According to the WHO estimates, neurological disorders are responsible for 4.5%-11% of all illnesses including low or high income economies. This is far higher as compared to the number of gastrointestinal disorders, or cancers, and is expected to increase further over the coming years.

However, higher cost of these treatment procedure may hamper the market growth during the corresponding period.

Some of Key Players:
Some of key the players in the market are BD (U.S.), Medtronic (U.S.), B. Braun Melsungen AG (Germany), Cook (U.S.), Teleflex Incorporated (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), NxStage Medical, Inc.(U.S.), and Poly Medicure Limited.

Segmentations:
The global dural arteriovenous fistulae treatment market is segmented on the basis of type, treatment, and end user.

On the basis of type, the market is segmented into type I, type II, and type III.

On the basis of application, the market is segmented into surgery, stereotactic radiosurgery, embolization, and others.

On the basis of end user, the market is segmented into hospitals & clinics, ambulatory surgical centers, and others.

GET FULL REPORT @ www.marketresearchfuture.com/reports/dural-arteriovenous-... .

Regional Analysis:
The Americas dominates the global dural arteriovenous fistulae treatment market owing to developing technology, increasing cases of brain injury, rising prevalence of neurological disorders, growing healthcare spending, and increasing government support for research & development. Furthermore, increasing R&D activities and the presence of major companies have fuelled the growth of the market in this region.
Europe holds the second position in the global dural arteriovenous fistulae treatment market. It is expected that the government support for research & development and availability of funds for research may drive the market in European region over the review period.

Asia Pacific is the fastest growing dural arteriovenous fistulae treatment market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing new opportunities in countries such as China, India, Japan, and South Korea projected to emerge as the fastest growing market across the globe. Furthermore, increasing demand for the neurological treatment may lead to the use of advanced equipment, which, in turn, will increase the growth of the dural arteriovenous fistulae treatment in the region.

On the other hand, the Middle East and Africa holds the least share of the market due to limited medical facilities, lack of funds for research and development, and poor political conditions, especially, in Africa.

GET DISCOUNT @ www.marketresearchfuture.com/check-discount/4580 .

Table of Contents:
Chapter 1. Report Prologue

Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations

Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation

Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
...
Chapter 11. Company Profiles
11.1 BD
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials
11.1.4 SWOT Analysis
11.2 Medtronic

11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis

11.3 B. Braun Melsungen AG
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis

11.4 Cook
11.4.1 Company Overview
11.4.2 Product/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis

11.5 Teleflex Incorporated
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial Overview
11.5.4 Key Developments
11.5.5 SWOT Analysis

11.6 Fresenius Medical Care AG & Co. KGaA
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis

11.7 NxStage Medical, Inc.
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Others

Chapter 12. MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s View Point
12.1.2 Unmet Needs Of The Market
12.2 Key Companies To Watch
12.3 Prediction Of Medical Devices Industry

...CONTINUED

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.
News-ID: 795433 • Views: 268
More releases More releases

You can edit or delete your press release here: